CAS: 90851-28-8 - (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-Glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-penten-1-yl β-D-glucopyranoside

Formule : C₃₂H₅₄O₁₃

InChI : InChI=1S/C32H54O13/c1-16(10-12-42-29-27(40)25(38)23(36)19(13-33)44-29)5-7-18-17(2)6-8-21-31(18,3)11-9-22(35)32(21,4)15-43-30-28(41)26(39)24(37)20(14-34)45-30/h10,18-30,33-41H,2,5-9,11-15H2,1,3-4H3

Code InChI : InChIKey=QIOMMMCQFIBVKA-UHFFFAOYSA-N

SMILES : OCC1OC(OCC=C(C)CCC2C(=C)CCC3C(C)(COC4OC(CO)C(O)C(O)C4O)C(O)CCC23C)C(O)C(O)C1O

Synonymes :

• β-D-Glucopyranoside, (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-pentenyl
• Goshonoside F 5
• (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-Glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-penten-1-yl β-D-glucopyranoside
• β-D-Glucopyranoside, (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-penten-1-yl
• β-D-Glucopyranoside, 5-[5-[(β-D-glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-pentenyl, [1R-[1α(E),4aβ,5β,6α,8aα]]-

β-D-Glucopyranoside, (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-penten-1-yl

CAS : 90851-28-8

• Formule : C₃₂H₅₄O₁₃
• Degré de pureté : 98.0%
• Masse moléculaire : 646.7634

Goshonoside F5

CAS : 90851-28-8

Goshonoside F5 has anti-inflammatory activity, it significantly inhibits the pro-inflammatory response induced by LPS, both …

• Formule : C₃₂H₅₄O₁₃
• Degré de pureté : 98%
• Couleur et forme : Solid
• Masse moléculaire : 646.771

Goshonoside F5

CAS : 90851-28-8

Goshonoside F5 is a clinical medication that has been shown to inhibit the production of …

• Formule : C₃₂H₅₄O₁₃
• Degré de pureté : Min. 95%
• Masse moléculaire : 646.8 g/mol